SAB Biotherapeutics Inc (SABS)
4.03
+0.01
(+0.25%)
USD |
NASDAQ |
May 03, 16:00
SAB Biotherapeutics Price: 4.03 for May 3, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 03, 2024 | 4.00 | 4.100 | 4.00 | 4.03 | 2533.00 |
| May 02, 2024 | 4.25 | 4.30 | 4.02 | 4.02 | 12181.00 |
| May 01, 2024 | 4.10 | 4.10 | 4.10 | 4.10 | 336.00 |
| Apr 30, 2024 | 4.13 | 4.300 | 4.12 | 4.29 | 805.00 |
| Apr 29, 2024 | 4.27 | 4.27 | 4.18 | 4.19 | 2681.00 |
| Apr 26, 2024 | 4.10 | 4.395 | 4.10 | 4.250 | 4877.00 |
| Apr 25, 2024 | 4.01 | 4.01 | 4.01 | 4.01 | 794.00 |
| Apr 24, 2024 | 4.400 | 4.400 | 4.40 | 4.40 | 731.00 |
| Apr 23, 2024 | 4.38 | 4.39 | 4.36 | 4.36 | 858.00 |
| Apr 22, 2024 | 4.505 | 4.65 | 4.36 | 4.39 | 1741.00 |
| Apr 19, 2024 | 4.31 | 4.31 | 4.29 | 4.29 | 891.00 |
| Apr 18, 2024 | 4.34 | 4.706 | 4.34 | 4.46 | 2927.00 |
| Apr 17, 2024 | 4.37 | 4.850 | 4.34 | 4.60 | 3644.00 |
| Apr 16, 2024 | 4.94 | 4.94 | 4.530 | 4.88 | 6922.00 |
| Apr 15, 2024 | 4.78 | 4.78 | 4.60 | 4.61 | 3060.00 |
| Apr 12, 2024 | 4.61 | 4.675 | 4.540 | 4.675 | 3497.00 |
| Apr 11, 2024 | 4.55 | 4.55 | 4.55 | 4.55 | 0.000 |
| Apr 10, 2024 | 4.49 | 4.55 | 4.49 | 4.55 | 2579.00 |
| Apr 09, 2024 | 4.492 | 4.492 | 4.46 | 4.46 | 1609.00 |
| Apr 08, 2024 | 4.25 | 4.46 | 4.25 | 4.46 | 1014.00 |
| Apr 05, 2024 | 4.45 | 4.62 | 4.250 | 4.34 | 4071.00 |
| Apr 04, 2024 | 4.546 | 4.546 | 4.25 | 4.42 | 9005.00 |
| Apr 03, 2024 | 4.834 | 4.857 | 4.46 | 4.46 | 4288.00 |
| Apr 02, 2024 | 4.72 | 4.72 | 4.469 | 4.50 | 8491.00 |
| Apr 01, 2024 | 4.51 | 4.51 | 4.26 | 4.29 | 5424.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
3.80
Minimum
Apr 12 2023
112.40
Maximum
Dec 01 2021
36.79
Average
10.38
Median
Price Benchmarks
| CEL-SCI Corp | 1.63 |
| AIM ImmunoTech Inc | 0.4048 |
| IGC Pharma Inc | 0.5112 |
| NovaBay Pharmaceuticals Inc | 0.0949 |
| Protalix BioTherapeutics Inc | 1.14 |
Price Related Metrics
| Price to Book Value | 0.6489 |
| Earnings Yield | -192.1% |
| Market Cap | 37.18M |